Assistant Professor of Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Paul G. Hammerness, MD
|
|
Give Review
Dr. Paul G. Hammerness practices Psychiatry. He studied medicine at Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth is ranked 37 in research and 29 in primary care medicine Paul Hammerness has written publications. He has 72 publications published with PubMed. The lastest paper is: 'Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment.'
Publications
- Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
- Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.
- An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration.
- A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder.
- Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.
- Examining the nature of the association between attention-deficit hyperactivity disorder and nicotine dependence: a familial risk analysis.
- Do stimulants improve functioning in adults with ADHD?: A review of the literature.
- The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the manchester driving behavior questionnaire.
- An evidence-based systematic review of vitamin a by the natural standard research collaboration.
- Do Stimulants Reduce the Risk for Cigarette Smoking in Youth with Attention-Deficit Hyperactivity Disorder? A Prospective, Long-Term, Open-Label Study of Extended-Rele...
- Cigarette smoking as a risk factor for other substance misuse: 10-year study of individuals with and without attention-deficit hyperactivity disorder.
- A Magnetic Resonance Spectroscopy Study of the Anterior Cingulate Cortex In Youth with Emotional Dysregulation.
- A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder.
- A pilot open label prospective study of memantine monotherapy in adults with ADHD.
- Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
- Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications.
- Supraventricular tachycardia in an adolescent with attention-deficit/hyperactivity disorder (ADHD).
- An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
- Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
- Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
- Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes.
- Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivi...
- An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
- Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.
- Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD.
- Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescents.
- Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration.
- Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
- A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder.
- An open-label trial of OROS methylphenidate in adults with late-onset ADHD.
- A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.
- Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot st...
- Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.
- A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity di...
- A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate.
- A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
- A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.
- A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
- Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective o...
- An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics.
- An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.
- Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review.
- Does ADHD moderate the manifestation of anxiety disorders in children?
- Essiac: systematic review by the natural standard research collaboration.
- Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration.
- Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
- Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study.
- Update on adult attention-deficit/hyperactivity disorder.
- The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families.
- An evidence-based systematic review of Aloe vera by the natural standard research collaboration.
- Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration.
- Risperidone treatment for ADHD in children and adolescents with bipolar disorder.
- Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic ...
- A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
- Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
- Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
- Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration.
- Reexamining the familial association between asthma and ADHD in girls.
- An evidence-based systematic review of belladonna by the natural standard research collaboration.
- Wild yam (Dioscoreaceae).
- Shark cartilage monograph: a clinical decision support tool.
- Kava monograph: a clinical decision support tool.
- Chaparral monograph:a clinical decision support tool.
- Marshmallow (Althaea officinalis L.) monograph.
- Thyme (Thymus vulgaris L.), thymol.
- An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
- St John''s wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.
- Linezolid: MAOI activity and potential drug interactions.
- Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment.
- Cognitive behavior therapy for treatment-refractory panic disorder.
- Drs. Hammerness and wilens reply.
Schools
Dartmouth College
Mass Gen Hospital
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- MultiPlan PPO
- PHCS Network PPO
Education
-
Massachusetts General Hospital -
Geisel School of Medicine at Dartmouth
Hospital
-
Newton-Wellesley Hospital -
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Domingo Pagan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel H. Marder, MD |
|
|
Dr. Sharon A. Salter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William B. Gault, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John B. Torous, MD |